About USANA Health Sciences Inc
Ticker
info
USNA
Trading on
info
NYSE
ISIN
info
US90328M1071
Industry
info
Packaged Foods
Sector
info
Consumer Defensive
CEO
info
Jim Brown
Headquarters
info
3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120
Employees
info
1,700
Website
info
usana.com
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Metrics
BasicAdvanced
Market cap
info
$369M
P/E ratio
info
21.97
EPS
info
$0.92
Dividend Yield
info
0.00%
Beta
info
0.65
Forward P/E ratio
info
11.92
EBIDTA
info
$69.8M
Ex dividend date
info
-
Price & volume
Market cap
info
$369M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
21.97
Forward P/E
info
11.92
PEG ratio
info
0.94
Trailing P/E
info
21.97
Price to sales
info
0.4
Price to book
info
0.68
Earnings
EPS
info
$0.92
EPS estimate (current quarter)
info
-$0.15
EPS estimate (next quarter)
info
$0.37
EBITDA
info
$69.8M
Revenues (TTM)
info
$913M
Revenues per share (TTM)
info
$48.71
Technicals
Beta
info
0.65
52-week High
info
$38.85
52-week Low
info
$18.48
50-day moving average
info
$21.94
200-day moving average
info
$27.77
Short ratio
info
1.58
Short %
info
5.62%
Management effectiveness
ROE (TTM)
info
3.15%
ROA (TTM)
info
3.74%
Profit margin
info
1.86%
Gross profit margin
info
$723M
Operating margin
info
0.57%
Growth
Quarterly earnings growth (YoY)
info
-3.70%
Quarterly revenue growth (YoY)
info
6.70%
Share stats
Outstanding Shares
info
18.3M
Float
info
9.6M
Insiders %
info
42.92%
Institutions %
info
61.78%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$39.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.64
$0.49
30.61%
Q4 • 24Beat
$0.73
$0.70
4.29%
Q1 • 25Beat
$0.74
$0.54
37.04%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$236M
$9.7M
4.09%
Q2 • 25
$214M
$-6.5M
-3.05%
Q3 • 25
-9.40%
-167.55%
-174.56%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$735M
$149M
20.28%
Q2 • 25
$727M
$145M
19.96%
Q3 • 25
-1.08%
-2.64%
-1.57%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$12.2M
$-4.2M
$-38.6M
$7.2M
Q2 • 25
$-2M
$-3.2M
$-1M
$-5.2M
Q3 • 25
-116.05%
-23.16%
-97.46%
-171.74%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a USANA Health Sciences Inc share?
Collapse

USANA Health Sciences Inc shares are currently traded for undefined per share.

How many shares does USANA Health Sciences Inc have?
Collapse

USANA Health Sciences Inc currently has 18.3M shares.

Does USANA Health Sciences Inc pay dividends?
Collapse

No, USANA Health Sciences Inc doesn't pay dividends.

What is USANA Health Sciences Inc 52 week high?
Collapse

USANA Health Sciences Inc 52 week high is $38.85.

What is USANA Health Sciences Inc 52 week low?
Collapse

USANA Health Sciences Inc 52 week low is $18.48.

What is the 200-day moving average of USANA Health Sciences Inc?
Collapse

USANA Health Sciences Inc 200-day moving average is $27.77.

Who is USANA Health Sciences Inc CEO?
Collapse

The CEO of USANA Health Sciences Inc is Jim Brown.

How many employees USANA Health Sciences Inc has?
Collapse

USANA Health Sciences Inc has 1,700 employees.

What is the market cap of USANA Health Sciences Inc?
Collapse

The market cap of USANA Health Sciences Inc is $369M.

What is the P/E of USANA Health Sciences Inc?
Collapse

The current P/E of USANA Health Sciences Inc is 21.97.

What is the EPS of USANA Health Sciences Inc?
Collapse

The EPS of USANA Health Sciences Inc is $0.92.

What is the PEG Ratio of USANA Health Sciences Inc?
Collapse

The PEG Ratio of USANA Health Sciences Inc is 0.94.

What do analysts say about USANA Health Sciences Inc?
Collapse

According to the analysts USANA Health Sciences Inc is considered a hold.